期刊文献+

磷酸二酯酶5抑制剂在心血管疾病治疗中的应用 被引量:3

Uses of phosphodiesterase 5 inhibitors in treatment of cardiac disease
原文传递
导出
摘要 磷酸二酯酶5抑制剂通过抑制磷酸二酯酶,延迟环磷酸鸟苷的分解,从而发挥血管平滑肌扩张作用。磷酸二酯酶5抑制剂在心力衰竭、肺动脉高压、高原肺水肿、高原肺动脉高压、高血压、雷诺综合征等的治疗中发挥重要作用。 Phosphodiesterase 5 inhibitors exert dilation of vascular smooth muscle by inhibiting phosphodiesterase and delaying break of cyclic guanosine 3', 5'-monophosphate. Phosphodiesterase 5 inhibitors exert important effects in the treatment of heart failure, pulmonary hypertension, high- altitude pulmonary edema, high-altitude pulmonary hypertension, hypertension, Raynaud' s phenomenon.
作者 黄震华
出处 《中国新药与临床杂志》 CAS CSCD 北大核心 2015年第6期409-412,共4页 Chinese Journal of New Drugs and Clinical Remedies
关键词 磷酸二酯酶抑制剂 心力衰竭 充血性 高血压 肺性 雷诺病 phosphodiesterase inhibitors heart failure, congestive hypertension, pulmonary Raynaud disease
  • 相关文献

参考文献24

  • 1LU Z, XU X, HU X, et al. Oxidative stress regulates |eft ventricular PDE5 expression in the failing heart[J]. Circulation, 2010, 121(13): 1474-1483.
  • 2NAGENDRAN J, ARCHER SL, SOLIMAN D, et d. Phosphodiesterase type 5 is highly expressed in the hypertrophied human right ventricle, and acute inhibition of phosphodiesterase type 5 improves contractility [J]. Circulation, 2007, 116(3) : 238-248.
  • 3LEWIS GD, SHAH R, SHAHZAD K, et ol. Sildenafil improves exercise capacity and quality of life in patients with systolic heart failure and secondary pulmonary hypertension [J]. Circulation, 2007, 116(14): 1555-1562.
  • 4HIRATA K, ADJI A, VLACHOPOULOS C, et aL Effect of sildenafil on cardiac performance in patients with heart failure[J]. Am J Cardiol, 2005, 96(10): 1436-1440.
  • 5BEHLING A, ROHDE LE, COLOMBO FC, et al. Effects of 5' - phosphodiesterase four- week long inhibition with sildenafil in patients with chronic heart failure: a double- blind, placebo- controlled clinical trial[J[. J Card Fail, 2008, 14(3): 189-197.
  • 6GUAZZI M, SAMAJA M, ARENA R, et al. Long-term use of sildenafil in the therapeutic management of heart failure[J]. J Am Coil Cardiol, 2007, 50(22): 2136-2144.
  • 7CHAU VQ, SALLOUM FN, HOKE NN, et ol. Mitigation of the progression of heart failure with sildenafil involves inhibition of RhoMRho-kinase pathway[j]. Am J Physiol Heart Circ Physiol, 2011, 300(6): H2272-H2279.
  • 8田丹,周达新,吕迁洲.肺动脉高压的药物治疗[J].中国新药与临床杂志,2013,32(3):181-186. 被引量:5
  • 9GALII N, GHOFRANI HA, TORBICKI A, et al. Sildenafil citrate therapy for pulmonary arterial hypertension[J]. N Engl J Med, 2005, 353(20): 2148-2157.
  • 10CROOM KF, CURRAN MP. Sildenafil: a review of its use in pulmonary arterial hypertension[J]. Drugs, 2008, 68 (3): 383- 397.

二级参考文献6

共引文献4

同被引文献38

引证文献3

二级引证文献24

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部